Readiness Assessment

Early stage teams usually know the science they want to move forward. The harder part is figuring out what regulators will expect and whether the program is actually ready.

We take a close look at your program, talk through your goals, and map out what needs attention before you start planning a submission. The goal is simple. Understand where you stand and what to do next.

When teams use this

• Preparing for a first IND, CTA, or EU CTR submission

• Navigating EU CTR or Member State strategy for the first time

• Checking whether the current data package is truly submission ready

• Entering early clinical development and needing a clear regulatory plan

What the process looks like

Introductory call

We talk through your program, timeline, and goals.

Document and data review

I review your clinical, preclinical, and CMC materials through an EU regulatory lens.

Readiness assessment

Key gaps, risks, and dependencies are identified early.

Roadmap

You receive a short, clear summary of next steps and sequencing.

Follow up support

Brief email support to answer questions and help you act on the plan.

Why this matters

Early regulatory decisions shape everything that comes after. Catching gaps now is much easier than fixing them mid submission. A readiness review helps you move forward with confidence and focus effort where it actually matters.

Why ApexVera

You work directly with me. No handoffs. No layers.

I’ve led EU CTR submissions and CTIS workflows and worked through real authority questions. The guidance is practical and based on what actually happens, not theory.

Next steps

If you'd like to talk through your program and see whether a readiness review makes sense, we can start with a short call.